Juno Pharmaceuticals Acquires Omega Laboratories
Juno Pharmaceuticals Corp., a leader in the commercialization of specialty pharmaceutical products, announced its acquisition of Omega Laboratories, one of Canada’s largest domestic specialty injectable pharmaceutical manufacturers located in Montreal. The acquisition is significant, solidifying Juno’s ability to improve drug supply in the Canadian market and resulting in a merged entity that is now the largest specialty generic injectable business in Canada.
Aird & Berlis LLP acted as lead counsel to Juno with a team led by Richard Epstein and Lorway Gosse and comprising Portia Biswas and Marna Alexandroff (Corporate/Commercial), Kanika Sharma and Jenaya McLean (Financial Services), as well as Francesco Gucciardo (Tax).ROBIC LLP acted as Quebec Commercial Counsel to Juno, with a team that was led by Francois Painchaud and comprising Amélie Côté and Panagiota (Betty) Koutsogiannis. BCF Avocats’ Nancy Boyle and Kevin Vinceletteacted as Quebec Labour and Employment Counsel to Juno, while Jacqueline Rowniak, Joel Cabelli and Mathiew Lalonde of Dentons provided legal counsel to National Bank of Canada, who provided financing for the acquisition.